Novo Holdings A/S

Holdings History for IO Biotech, Inc. - Common (IOBT)

Symbol: IOBT on Nasdaq
Investment type: Equity / Common
Latest Disclosed Shares Owned: 2,469,135 shares
Security Ownership %: 3.3%

Shares, Excluding Options vs Price

Value, Excluding Options

Novo Holdings A/S ownership in IO Biotech, Inc. Common (IOBT)

23 Jan 2026 - Novo Holdings A/S has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2,469,135 shares of IO Biotech, Inc. Common (IOBT). This represents 3.3% ownership of the company. In their previous filing dated 19 Aug 2025, Novo Holdings A/S had reported owning 4,981,588 shares, indicating a decrease of +50%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Novo Holdings A/S	3.3%	-57%	$1,827,160	2,469,135	-2,512,453	-50%	$0.74	13D/A	21 Jan 2026	23 Jan 2026, 19:05
Novo Holdings A/S	7.3%		$10,560,967	4,981,588			$2.12	13D/A	11 Aug 2025	19 Aug 2025, 17:09

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.12%	0%	$1,529,833	2,512,453	0		$0.61	Q4 2025
30 Sep 2025	0.06%	-0.02%	$912,272	2,512,453	-841,996	-25%	$0.36	Q3 2025
30 Jun 2025	0.33%	0%	$4,662,684	3,354,449	0		$1.39	Q2 2025
31 Mar 2025	0.28%	0%	$3,656,349	3,354,449	0		$1.09	Q1 2025
31 Dec 2024	0.19%	0%	$3,086,093	3,354,449	0		$0.92	Q4 2024
30 Sep 2024	0.17%	-0.06%	$3,522,171	3,354,449	-1,075,000	-24%	$1.05	Q3 2024
30 Jun 2024	0.28%	-0.04%	$5,182,455	4,429,449	-658,809	-13%	$1.17	Q2 2024
31 Mar 2024	0.66%	-0.09%	$8,802,686	5,088,258	-658,809	-11%	$1.73	Q1 2024
31 Dec 2023	0.72%	0%	$10,804,486	5,747,067	0		$1.88	Q4 2023
30 Sep 2023	0.6%	+0.26%	$8,103,364	5,747,067	+2,469,135	+75%	$1.41	Q3 2023
30 Jun 2023	0.5%	0%	$6,408,357	3,277,932	0		$1.95	Q2 2023
31 Mar 2023	0.44%	0%	$6,146,123	3,277,932	0		$1.88	Q1 2023
31 Dec 2022	0.47%	0%	$7,539,244	3,277,932	0		$2.30	Q4 2022
30 Sep 2022	0.56%	0%	$8,883,000	3,277,932	0		$2.71	Q3 2022
30 Jun 2022	0.75%	0%	$15,308,000	3,277,932	0		$4.67	Q2 2022
31 Mar 2022	0.92%	0%	$17,373,000	3,277,932	0		$5.30	Q1 2022
31 Dec 2021	0.99%	+0.99%	$20,979,000	3,277,932	+3,277,932	NEW	$6.40	Q4 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.